Clinical trials
Obstructive Pulmonary Disease clinical trials
Below are recruiting obstructive pulmonary disease clinical trials, each written for real people, not researchers. We’re tracking 346 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07072039Recruiting
Emergency team check for acute COPD flare-ups
This study looks at how well paramedics can evaluate a sudden worsening of COPD (a lung disease that makes it hard to breathe). It may help improve emergency care for COPD patients in the UMass Memorial system.
Worcester, MassachusettsAges 40 years+ - NCT07074093Enrolling by invitation
Smartphone app to help COPD patients with air pollution
This study tests whether a smartphone app can help people with COPD breathe better by giving them tips to avoid air pollution. If you live in Salamanca and can use a smartphone, this app might help you manage your condition.
Salamanca, SalamancaAges 18 years+ - NCT07065162Recruiting
Touch and breathing exercises for COPD
This trial tests two techniques—a gentle touch method and a breathing exercise routine—to see which helps people with mild to moderate COPD feel better and breathe easier.
Lahore, Punjab ProvinceAges 45–65 - NCT07059091RecruitingPhase 2
Allergy medicine for COPD with indoor allergies
This study tests if omalizumab, an allergy medicine, can help people with COPD who are allergic to common indoor allergens and have had recent flare-ups. It aims to see if reducing allergic reactions can improve COPD control.
Birmingham, AlabamaAges 40 years+ - NCT07051707Recruiting
Study of a new lung treatment for people with COPD
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
Birmingham, AlabamaAges 40–80 - NCT07037836RecruitingPhase 2
Inhaled treprostinil for COPD with low oxygen
This trial tests an inhaled medication called treprostinil (Tyvaso) to see if it can help people with COPD who have low blood oxygen levels. You may qualify if you have chronic bronchitis, use oxygen at rest or during exercise, and meet specific lung function criteria.
Durham, North CarolinaAges 40 years+ - NCT07031336Recruiting
Photon-counting CT for better lung scans
This trial is testing a new type of CT scanner (photon-counting CT) for chest imaging. If you are already in the Duke-COPDGene study, you may be invited to also get this special scan to see if it gives clearer pictures of your lungs.
Durham, North CarolinaAges Any age - NCT07022704Recruiting
Doxapram to help COPD patients breathe easier off the ventilator
This trial tests if the drug doxapram can improve diaphragm movement in COPD patients who are being taken off a ventilator during a breathing trial. It aims to make the transition smoother and more successful.
Cairo, Cairo GovernorateAges 20–65 - NCT04664491Recruiting
Program to reduce COPD flare-ups with standardized care
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
Beijing, Beijing MunicipalityAges 40 years+ - NCT07000604Recruiting
How inhaler use affects oral health in COPD patients
This study looks at how using a metered dose inhaler (a common type of inhaler) might impact your mouth and teeth if you have COPD. It aims to help understand and improve oral care for people using these inhalers.
ÇankırıAges 35–80 - NCT06974981Recruiting
Using lung cancer screening to find and treat COPD
This study looks at how lung cancer screening can also help find and manage COPD, a lung condition that often goes undetected. If you are a current or former smoker and meet certain age and smoking history criteria, you may join to help improve screening and care for both lung cancer and COPD.
Philadelphia, PennsylvaniaAges 50–80 - NCT06976762Enrolling by invitation
Light-based muscle oxygen measurements in COPD with kidney disease
This study uses a special light-based device (near-infrared spectroscopy) to measure muscle oxygen levels in people who have both COPD and chronic kidney disease. Researchers want to see if these measurements can help predict how the disease progresses, which could lead to better monitoring and treatment.
Tokat ProvinceAges 18–80 - NCT06967324Recruiting
Tailored support for advanced COPD with flare-ups
This study tests a personalized care program for people with advanced COPD who have had a flare-up in the last year. It aims to improve quality of life and reduce symptoms by offering extra support at home.
HvidovreAges 65 years+ - NCT06958666Recruiting
Comparing two breathing exercises for COPD symptoms
This study compares two breathing exercise methods (DITM vs IMT) for people with COPD to see which helps improve symptoms and quality of life better. It's for people who are already using a specific type of inhaler.
Hangzhou, ZhejiangAges 40 years+ - NCT04220463Recruiting
Hypnosis during noninvasive breathing support for ICU lung illness
This trial tests whether hypnosis can help people in the ICU who need noninvasive breathing support (breathing help without a tube) for breathing flare-ups related to COPD and/or obesity. It aims to make this treatment easier and safer while you are awake.
Rennes, Brittany RegionAges 18 years+ - NCT06883305RecruitingPhase 3
Testing tezepelumab for moderate to severe COPD
This trial tests tezepelumab, an injected medication, for people with moderate to very severe COPD who still have flare-ups despite using standard inhalers. It may help reduce flare-ups and improve breathing for those with higher eosinophil levels.
Foley, AlabamaAges 40–80 - NCT06882863Enrolling by invitation
Study to help reduce sitting in severe COPD
This study tests whether a nurse can help you sit less during the day if you have severe COPD. A nurse will visit you at home for motivational interviews to help you become more active.
RoskildeAges 65 years+ - NCT06888557Recruiting
Smartphone help for COPD: improve quality of life
This trial tests a smartphone-based program to help people with COPD manage their condition and feel better. You will use WhatsApp or WeChat to get support and track your activity.
Hong Kong, Hong KongAges 40 years+ - NCT06878261RecruitingPhase 3
Tezepelumab for moderate to very severe COPD
This study tests a new medication called tezepelumab (given as a shot) to see if it can reduce COPD flare-ups in people with moderate to very severe COPD who have had recent flare-ups despite using inhalers. It may be an option for those with higher levels of eosinophils (a type of white blood cell) in their blood.
Birmingham, AlabamaAges 40–80 - NCT06862206Recruiting
Benralizumab study for severe asthma in China
This study looks at people in China with severe eosinophilic asthma who are starting a new medicine called benralizumab. It will collect information about their symptoms and quality of life to understand who benefits most.
AnhuiAges Any age - NCT06858748Recruiting
Mucus in airways: asthma, COPD, and chronic cough study
This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.
Vancouver, British ColumbiaAges 18 years+ - NCT06827379Enrolling by invitation
Breathing exercise for muscle and nerve health in COPD
This trial tests whether a special breathing exercise (inspiratory muscle training) can improve how your muscles work and your body's automatic responses, like heart rate. It's a one-time session for people with stable COPD.
João Pessoa, ParaíbaAges 40–75 - NCT06820749Enrolling by invitationPhase 2
Study of HSK31858 tablets for lung mucus conditions
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06780046Recruiting
COPD study for Brazilian patients
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
Aparecida de GoiâniaAges 18 years+
Hear when a new Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obstructive pulmonary disease?
- Yes. Clin2 currently lists 346 recruiting obstructive pulmonary disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obstructive pulmonary disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obstructive pulmonary disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.